Axsome Therapeutics Inc
AXSM
$204.26-1.70%
Delayed · as of Sep 21, 2026, 1:46 PM ET
Mkt cap
$11.96B
EV/Sales
18.5
P/E ratio
N/A
FY2025 Revenue
$638.50M
EPS (TTM)
$-3.75
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-28.69%
Beta
0.60
Div yield
N/A
Sector
Healthcare
Axsome Therapeutics Inc (AXSM) is a biotechnology company listed on US.
Latest reported AXSM revenue for 2025-12-31 was $638.5M. Net income was -$183.2M. Revenue was up 65.5% from 2024-12-31 to 2025-12-31. AXSM currently screens at market cap $11.96B.
Use this AXSM research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full AXSM income, balance, and cash tables.
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
Axsome Therapeutics Inc (AXSM) is a biotechnology company in the Healthcare sector.
Latest cached Axsome Therapeutics Inc (AXSM) revenue for Dec 31, 2025 was $638.5M. Net income was -$183.2M. Statements: https://lician.com/financials/axsm
Axsome Therapeutics Inc (AXSM) market capitalization is $11.96B on the latest cached snapshot.
Axsome Therapeutics Inc (AXSM) cached previous close $207.78; day range $203.47 – $210.85; volume 179,771. Session quote: https://lician.com/quote/axsm
Axsome Therapeutics Inc (AXSM) latest cached earnings event is "AXSM earnings" on Aug 10, 2026. Earnings calendar: https://lician.com/earnings
The latest cached AXSM filing is 8-K · Aug 10, 2026. Filings: https://lician.com/sec/axsm